Advertisement · 728 × 90

Posts by ACCP ID PRN

Post image

🤖 Dr. Bradley Langford presents ideas on how we can leverage AI to assist ID clinicians in stewardship initiatives!

💭 “Once a new technology rolls over you, if you're not part of the steamroller, you're part of the road.”
~ Stewart Brand

#ESCMIDGlobal2026 #IDXPosts #AI #ASP

1 day ago 0 0 0 0
Post image Post image Post image Post image

🎊 Simply AMAZING to see so many of our members and colleagues at tonight’s social event in Munich, Germany!!! 🇩🇪🍻

✈️ For those returning home, we wish you safe travels the next few days!

@SIDPharm @accpinfdprn

#ESCMIDGlobal2026 #IDXPosts

1 day ago 1 0 0 0
Post image

Wishing everyone a Happy Vaisakhi!

#happyvaisakhi #celebratingspring #courage #equality

1 day ago 0 0 0 0

🚨🚨🚨 Final reminder that our ACCP ID PRN/SIDP social event is happening TONIGHT (Monday, April 20th) from 18:30-21:30 at Löwenbräukeller in Munich!

👋🏼 Hope to see you there!

1 day ago 0 0 0 0
Post image

🆕 NEW to the SSC 2026 guidelines: Candida fungal biomarkers to initiate or stop anti-fungal therapy!

#ESCMIDGlobal2026 #antifungal #sepsis #survivingsepsis

2 days ago 0 0 0 0
Post image Post image

🩸The Surviving Sepsis Campaign group recently updated their guidelines in 2026!

⏱️ Dr. Willem Joost Wiersinga helps us review the timing and duration of antibiotic administration!

#ESCMIDGlobal2026 #IDXPosts #survivingsepsis #sepsis

2 days ago 1 0 0 1
Post image

April 📆is #nationalminorityhealthmonth, let's all Be the Source for Better Health👍!

2 days ago 0 0 0 0
Post image Post image Post image

💊 Dr. Ili Margalit presents key antimicrobial agents for TB, NTM, and Novartis infections! Great review especially with recent updates in TB management and the addition of Moxifloxacin to recommended regimens.

#ESCMIDGlobal2026 #IDXPosts #TB #nocardia

2 days ago 1 0 1 0
Post image

⭐️ Excellent table from Dr. Giusey Tiseo outlining key studies researching IV-to-PO stepdown!

🏥 All three studies showed a decreased LOS in the IV-to-PO stepdown group!

#ESCMIDGlobal2026 #IDXPosts #IVtoPO #Stepdowntherapy

2 days ago 2 1 0 0
Advertisement
Post image

🔬 Poster sessions started today!!! Who else is here to learn more about the AWESOME research that’s going on?! 🙋🏻‍♂️🙋🏼‍♀️

#ESCMIDGlobal2026 #Research #IDXPosts

3 days ago 0 0 0 0
Post image

🧪 Great review on severe community-acquired MRSA and PSAR pneumonia risk factors by Dr. Pedro Povoa!

#ESCMIDGlobal2026 #IDXPosts #Pneumonia

3 days ago 0 0 0 0
Post image Post image

🤔 Do you use ciprofloxacin TDM at your institution?

🔬 Dr. Koch presents excellent research showing how 400 mg TID may not be sufficient in reaching appropriate levels in the body!

#IDXPosts #ESCMIDGlobal2026 #PKPD #Research

4 days ago 0 0 0 0
Post image Post image

🧠 Penetration ability of drugs greatly affects the concentration at difficult to reach infection sites like the CSF!

💥 Mind-blowing to see how a serum concentration of 30 mg/L was equivalent to just 4 mg/L in the CSF in Dr. König’s case!

#PKPD #IDXPosts #ESCMIDGlobal2026

4 days ago 0 0 0 0
Post image Post image

📊 Recent data published in critical care journals recommend assessing Volume of Distribution (Vd) for loading doses and clearance (CL) for maintenance doses.

‼️ There are so many factors to consider with CRRT patients including protein binding, Vd, CL, and PD of drugs!

#PKPD

4 days ago 0 0 1 0
Post image

📈 PK/PD of drugs is a key consideration in appropriate antimicrobial dosing, especially in special populations!

➡️ Very excited for Drs. Christina König and Brigit Koch for brining us through this insightful journey!

#ESCMIDGlobal2026 #IDXPosts #PKPD #Research

4 days ago 0 0 1 0
Post image

☠️ Mortality is not enough!

🔬Several other factors are just as important to look at with clinical research!

#IDXPosts #ESCMIDGlobal2026 #research

4 days ago 0 0 0 0
Advertisement
Post image Post image

Infectious diseases research endpoints such as mortality are the most common outcomes observed.

But what if we don’t have to use mortality all the time?

Drs. Calbo and Katsounas provided excellent info on ways we can include other outcomes in research!

#IDXPosts #ESCMIDGlobal

4 days ago 1 0 1 0
Post image

Make sure you stay hydrated! 💧

Get your free ESCMID bottle at the Beacon tables in the main atrium!

Hydration stations are scattered across the venue!

#hydration #conferences #ESCMIDGlobal2026

5 days ago 0 0 0 0
Post image

🌅 The day has come!

🦠 ESCMID Global 2026 starts TODAY!

🇩🇪 Whether you’re attending in-person or online, there are so many sessions to attend and learn from! We hope to see some of you here!

#IDXPosts #ESCMIDGlobal2026 #infectiousdiseases #research #munich

5 days ago 0 0 1 0
Post image

Can’t make it in person? Virtual registration is now open for the MAD-ID & SIDP 2026 Annual Meeting!

🔗 buff.ly/0v2rJnt

@sheaepi.bsky.social @cidrap.bsky.social @pidsociety.bsky.social @accpinfdprn.bsky.social @marrcoalition.bsky.social

6 days ago 2 3 0 0

ESCMID 2026 is in two days! 🎉

Are you ready? Download the ESCMID Global app to help create your own schedule and network with colleagues! 📲

We hope to see some of you very soon in Munich, Germany! 🇩🇪

#ESCMIDGlobal2026 #science #research #infectiousdiseases

6 days ago 0 0 0 0
Post image

The gates close at midnight! Early bird pricing ends tonight, register now for the MAD-ID & SIDP 2026 Annual Meeting!

🔗 buff.ly/KWgqZS6

@sheaepi.bsky.social @cidrap.bsky.social @pidsociety.bsky.social @accpinfdprn.bsky.social @marrcoalition.bsky.social

1 week ago 0 1 0 0

🚨 STI Awareness Week is here!

📊According to the CDC, about 1/5 of the U.S. had an STI on any given day in 2018.

💰 STI associated healthcare costs were nearly $16 billion!

Learn more about how STIs impact our lives and help reduce the stigma for treatment!

#STIWeek #InfectiousDiseases

1 week ago 0 0 0 0
Advertisement

Reminder early bird registration ends tomorrow!

1 week ago 0 0 0 0
Preview
Pharmacological reduction of neutrophil infiltration reduces Clostridioides difficile infection severity | mBio Clostridioides difficile remains a leading cause of antibiotic-associated diarrhea worldwide and a major healthcare burden. While antibiotics are commonly used to treat CDI, high antibiotic resistance...

🚨 RAD RESEARCH ALERT! 🚨

🦠 C. diff infection remains a major healthcare burden.

🔬 Keenan and colleagues found that giving the prostaglandin analog misoprostol in mice helps reduces CDI severity and improve outcomes via decreased inflammation!

#radresearch #cdiff #science

1 week ago 0 0 0 5
Post image

David Cluck emphasizes the unknowns and lack of quality data.

1 week ago 0 0 0 0
Post image

Cynthia Nguyen @cynth-id.bsky.social says to respect how challenging biofilm-embedded bacteria are to eradicate. Dormant persister cells are responsible for recalcitrant infections.

1 week ago 0 0 1 1

ID pharmacists (and ID PRN members) debate suppressive antibiotic therapy (SAT) for PJI, VGI, and CIEDI at #SHEASpring2026! When is it indicated? How long should we continue SAT? And where does stewardship fit in?

@rachelbpharmd.bsky.social

1 week ago 0 0 1 1

Consider the 5 Rights of Clinical Decision Support when implementing your #stewie interventions

1. Right information
2. Right person
3. Right format
4. Right channel
5. Right timing in workflow

Simon Parzen-Johnson at #SHEASpring2026

1 week ago 0 0 0 0
Post image Post image

Lauren O'Brien at #SHEASpring discusses a framework for leading effective meetings. Determine the intended Purpose and Product ahead of time. If these don't exist, can the meeting be avoided and an email sent instead?

1 week ago 0 0 0 0
Advertisement